Ossenkoppele GJ - Search Results

1

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Janssen JJWM, Löwenberg B, Manz M, Biemond BJ, Westerweel PE, Klein SK, Fehr M, Sinnige HAM, Efthymiou A, Legdeur MCJC, Pabst T, Gregor M, van der Poel MWM, Deeren D, Tick LW, Jongen-Lavrencic M, van Obbergh F, Boersma RS, de Weerdt O, Chalandon Y, Heim D, Spertini O, van Sluis G, Graux C, Stüssi G, van Norden Y, Ossenkoppele GJ. Janssen JJWM, et al. Among authors: ossenkoppele gj. Leukemia. 2022 Sep;36(9):2189-2195. doi: 10.1038/s41375-022-01657-3. Epub 2022 Jul 22. Leukemia. 2022. PMID: 35869267 Clinical Trial.

2

VLA molecule expression may be involved in the release of acute myeloid leukaemic cells from the bone marrow.

Denkers IA, de Jong-de Boer TJ, Beelen RH, Ossenkoppele GJ, Langenhuijsen MM. Denkers IA, et al. Among authors: ossenkoppele gj. Leuk Res. 1992;16(5):469-74. doi: 10.1016/0145-2126(92)90172-4. Leuk Res. 1992. PMID: 1625472

3

Quantitative enzyme determination in acute myeloid leukemia.

Ossenkoppele GJ, Wijermans PJ, Huijgens PC, Nauta JJ, Langenhuijsen MM. Ossenkoppele GJ, et al. Leuk Res. 1991;15(6):481-6. doi: 10.1016/0145-2126(91)90059-3. Leuk Res. 1991. PMID: 1650411

4

Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity.

Ossenkoppele GJ, Wijermans PW, Nauta JJ, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Eur J Cancer. 1991;27(7):842-5. doi: 10.1016/0277-5379(91)90130-6. Eur J Cancer. 1991. PMID: 1834114

5

Differentiation induction of HL60 cells in a long-term bone marrow culture of acute myeloid leukemia.

Ossenkoppele GJ, Denkers I, Wijermans P, Huijgens PC, Nauta JJ, Beelen RJ, Langenhuijsen MM. Ossenkoppele GJ, et al. Leuk Res. 1990;14(7):611-6. doi: 10.1016/0145-2126(90)90015-2. Leuk Res. 1990. PMID: 2388472

6

Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducer.

Ossenkoppele GJ, Wijermans PW, Nauta JJ, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Leuk Res. 1989;13(7):609-14. doi: 10.1016/0145-2126(89)90129-x. Leuk Res. 1989. PMID: 2548044

7

Radiotoxicity of 67-gallium on myeloid leukemic blasts.

Jonkhoff AR, Huijgens PC, Versteegh RT, van Lingen A, Ossenkoppele GJ, Dräger AM, Teule GJ. Jonkhoff AR, et al. Among authors: ossenkoppele gj. Leuk Res. 1995 Mar;19(3):169-74. doi: 10.1016/0145-2126(94)00130-3. Leuk Res. 1995. PMID: 7700078

8

Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia.

van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, van Hooff MH, Dräger AM, Huijgens PC, Langenhuijsen MM. van de Loosdrecht AA, et al. Among authors: ossenkoppele gj. Leukemia. 1994 Aug;8(8):1392-400. Leukemia. 1994. PMID: 8057679

9

Adhesive capacity of human long-term bone marrow cultures from normals and patients with acute myeloid leukaemia: the influence of adhesion molecules.

Denkers IA, de Jong-de Boer TJ, Beelen RH, Ossenkoppele GJ, Nauta JJ, Langenhuijsen MM. Denkers IA, et al. Among authors: ossenkoppele gj. Leuk Res. 1993 Mar;17(3):255-61. doi: 10.1016/0145-2126(93)90009-a. Leuk Res. 1993. PMID: 8450674

10

Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.

Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Währer DC, Eekman CA, Schoester M, Lankelma J, Pinedo HM, Löwenberg B, Schuurhuis GJ. Broxterman HJ, et al. Among authors: ossenkoppele gj. Blood. 1996 Jun 1;87(11):4809-16. Blood. 1996. PMID: 8639853 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page